Isotretinoin, Interferon Alfa-2b, and Paclitaxel in Treating Patients With Stage IV, Recurrent, or Persistent Cervical Cancer

This study has been terminated.

( Slow accrual and lack of study drug )

Study NCT00138151 Information provided by University of Medicine and Dentistry New Jersey

First Received: August 29, 2005 Last Updated: January 27, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	December 2009
Primary Completion Date:	October 2009 (Final data collection date for primary outcome measure)